Masutaka Higashimura
Overview
Explore the profile of Masutaka Higashimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yagisawa K, Okazuka K, Toba K, Urushiyama M, Kuroha T, Izumi N, et al.
Int J Hematol
. 2012 Feb;
95(4):420-7.
PMID: 22362009
Myelodysplastic syndrome (MDS) is relatively common in the elderly, and aging of populations is progressing in developed nations, notably so in Japan. The major age group in Japan and Sado...
2.
Furukawa T, Kurasaki-Ida T, Masuko M, Tsukada N, Okazuka K, Sato N, et al.
Int J Hematol
. 2010 Jun;
92(1):144-51.
PMID: 20533008
Pharmacological study is predictably effective in establishing an optimal monitoring strategy for the usage of cyclosporine A (CsA) to prevent graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation recipients....
3.
Makiyama Y, Toba K, Kato K, Hirono S, Ozawa T, Saigawa T, et al.
Tohoku J Exp Med
. 2008 Aug;
215(4):299-306.
PMID: 18679003
Restenosis is a major problem in percutaneous catheter intervention (PCI) for coronary artery stenosis in patients with acute myocardial infarction. Coronary restenosis arises from intimal hyperplasia, i.e., hyperplasia of the...
4.
Fujiwara M, Satou N, Izumi N, Shibasaki Y, Higashimura M, Tsukada N, et al.
Gan To Kagaku Ryoho
. 2007 Nov;
34(11):1793-8.
PMID: 18030012
Fifty-seven patients with acute myelogenous leukemia (AML) received the following treatment in our hospital between May 1992 and April 2005. Group A: combination of enocitabine, daunorubicin, 6-mercaptopurine riboside and prednisolone...
5.
Oda M, Kato K, Toba K, Otaki K, Kitajima T, Ikarashi N, et al.
J Cardiol
. 2007 Nov;
50(4):235-42.
PMID: 17987839
Objectives: Autologous bone marrow implantation (BMI) is effective to treat critical limb ischemia, but the long-term prognosis is not clear. The outcome of BMI treatment for ischemic legs was investigated...
6.
Takizawa J, Aoki S, Kurasaki T, Higashimura M, Honma K, Kitajima T, et al.
Am J Hematol
. 2007 Aug;
82(12):1113-5.
PMID: 17696205
This study reports the first well-documented case of adult T-cell leukemia (ATL) successfully treated with unrelated cord blood transplantation (UCBT). A 49-year-old woman was diagnosed with acute-type of ATL. Chemotherapy...
7.
Ozawa T, Kato K, Toba K, Oda M, Isoda M, Asami F, et al.
Int J Cardiol
. 2007 Aug;
130(1):106-8.
PMID: 17673315
Bone marrow implantation (BMI) has been utilized for the treatment of limb ischemia, however, serum markers have not yet been reported to express the degree of limb ischemia. We analyzed...